PRNewsWire · KZIA · November 2, 2026

Kazia Therapeutics Announces Two Abstracts on Paxalisib Tumor and Immune Reprogramming Research Accepted for Poster Presentation at 2026 San Antonio Breast Cancer Symposium

Get the app for more

Explore stock news, insights and company research.